Contact: Tom Hughes
University of North Carolina Health Care
Caption: “The results of this study will be helpful to both doctors and patients in shared decision-making about which of these two drugs is better suited for a particular patient,” said John B. Buse, M.D., Ph.D., first author of the study. Dr. Buse is division chief of endocrinology and metabolism in the University of North Carolina School of Medicine and director of the UNC Diabetes Care Center.
Credit: UNC Medical Center News Office
Usage Restrictions: None
Related news release: Head-to-head trial of 2 diabetes drugs yields mixed results